---
title: "Adalimumab"
ocid: "ocds-r6ebe6-0000557271"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000557271"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000557271.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000557271.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"THE AUTHORITY\")"
published: "2018-12-13"
---

# Adalimumab

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")  
Current stage: Award  
OCID: ocds-r6ebe6-0000557271

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000557271)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000557271.json)

## Summary

The Common Services Agency, also known as NHS National Services Scotland, is inviting tenders for the supply of Adalimumab in 20mg, 40mg, and 80mg presentations as part of a Framework Agreement intended for health boards throughout NHS Scotland. This procurement process is currently in the Award stage, with a value estimated at £130,023,407. The submission period concluded on 24th October 2018, and the procurement was conducted using an Open procedure, allowing for broad participation from suppliers within the healthcare industry.

This tender represents a significant opportunity for businesses specialising in pharmaceuticals, particularly those able to supply high-quality biological products and demonstrate compliance with relevant regulations, such as the UK Marketing Authorisation. Companies that possess certifications like ISO 9001 and prove capability in managing supply chain logistics will find this tender particularly suitable. With the contract awarded to multiple suppliers, businesses have a competitive landscape that encourages collaboration and innovative solutions in meeting NHS requirements.

## Notice

The Framework Agreement is for the supply of adalimumab 20mg, 40mg, 80mg presentations to health boards across NHS Scotland.

### Lot Information

Lot 1

This Framework Agreement is for the supply of adalimumab presentations to NHS Scotland. This will require supply of the Goods direct to hospitals and nominated home delivery supplier(s) as directed by the Authority. The Framework Agreement includes the provision of Goods only and Goods with manufacturer funded homecare. Each product line has been awarded as an individual Lot. Each lot has been awarded as an unranked multi supplier Framework to five (5) suppliers.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC340062 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 13 Dec 2018 |
| Submission deadline | 24 Oct 2018 |
| Future notice date | Not specified |
| Award date | 19 Nov 2018 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £130,023,407 |
| Lots value | £130,023,047 |
| Awards value | Not specified |
| Contracts value | £42,246,884 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 5 |
| Supplier names | ABBVIE; AMGEN; BIOGEN IDEC; GENERICS [UK] T/A MYLAN; SANDOZ |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 13 Dec 2018 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC340062
- 20 Sep 2018 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP332007

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP332007
  Adalimumab - The Framework Agreement is for the supply of adalimumab 20mg, 40mg, 80mg presentations to health boards across NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC340062
  Adalimumab - The Framework Agreement is for the supply of adalimumab 20mg, 40mg, 80mg presentations to health boards across NHS Scotland.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000557271
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000557271. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000557271.json.